Decoding MHC loss: Molecular mechanisms and implications for immune resistance in cancer

Documenti analoghi

• Pan‐cancer multi‐omics reveals DCAF7 as an immune‐modulating prognostic driver and Wnt/β‐catenin activator in hepatocellular carcinoma
  di: Ruina Luan, et al.
  Pubblicazione: (2025)
• Copper in colorectal cancer: From copper‐related mechanisms to clinical cancer therapies
  di: Yuhong Wang, et al.
  Pubblicazione: (2024)
• The role of long non‐coding RNAs in lung cancer metastasis: Molecular mechanisms, pathogenesis and clinical implications
  di: Musaffe Tuna, et al.
  Pubblicazione: (2025)
• Multi‐omics molecular phenotyping reveals the potential mechanisms of chemotherapy response and resistance in small cell lung cancer
  di: Ying Cheng, et al.
  Pubblicazione: (2024)
• Single‐cell and spatial transcriptomics uncover neoadjuvant chemotherapy‐resistant malignant cells with inhibitory signalling on B cells in gastric cancer
  di: Pei‐Yi Han, et al.
  Pubblicazione: (2026)